CI
CI.US The Cigna Group
- Market cap
- USD 78.3B
- P/E
- 13.1x
- P/B
- 1.80x
- ROE
- 14.6%
- Dividend yield
- 2.06%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CI.US undervalued?
Graham numberCI.US trades 2.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
The Cigna Group fundamental analysis
No fundamental analysis for The Cigna Group yet.
The Cigna Group stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formu…
Full company profileThe Cigna Group financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
The Cigna Group annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 39.8B | 41.8B | 48.7B | 154B | 160B | 174B | 181B | 195B | 247B | 275B | 285B |
| Gross Profit | 13.0B | 14.1B | 16.3B | 25.1B | 24.2B | 23.0B | 23.5B | 25.2B | 26.0B | 26.0B | 31.8B |
| Operating Income | 3.09B | 3.94B | 4.16B | 8.08B | 8.15B | 7.94B | 8.45B | 8.54B | 9.42B | 9.13B | 9.91B |
| EBITDA | 3.86B | 4.69B | 5.56B | 12.5B | 11.4B | 11.1B | 11.5B | 12.1B | 12.5B | 11.7B | 13.1B |
| Net Income | 1.87B | 2.24B | 2.64B | 5.10B | 8.46B | 5.37B | 6.70B | 5.16B | 3.43B | 5.96B | 6.34B |
| EPS | 7.19 | 9.17 | 11 | 13 | 23 | 16 | 21 | 17 | 12 | 22 | 24 |
| Balance Sheet | |||||||||||
| Total Assets | 59.4B | 61.8B | 153B | 156B | 155B | 155B | 144B | 153B | 156B | 158B | 158B |
| Total Liabilities | 45.6B | 48.0B | 112B | 110B | 105B | 108B | 99.0B | 106B | 115B | 116B | 114B |
| Shareholders' Equity | 13.7B | 13.7B | 41.0B | 45.3B | 50.3B | 47.1B | 44.9B | 46.2B | 41.0B | 41.7B | 43.4B |
| Cash & Short-term Investments | 3.88B | 3.17B | 5.90B | 5.56B | 11.5B | 6.00B | 6.83B | 8.75B | 8.22B | 7.68B | 7.30B |
| Total Debt | 5.03B | 5.44B | 42.5B | 38.0B | 33.6B | 34.3B | 31.6B | 30.9B | 32.0B | 31.5B | 31.1B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 4.03B | 4.09B | 3.77B | 9.49B | 10.4B | 7.19B | 8.66B | 11.8B | 10.4B | 9.60B | 4.37B |
| Capital Expenditure | 461M | 471M | 528M | 1.05B | 1.09B | 1.15B | 1.30B | 1.57B | 1.41B | 1.21B | 1.12B |
| Free Cash Flow | 3.57B | 3.62B | 3.24B | 8.44B | 9.26B | 6.04B | 7.36B | 10.2B | 8.96B | 8.39B | 3.25B |
| Ratios | |||||||||||
| ROE | 13.6% | 16.3% | 6.4% | 11.3% | 16.8% | 11.4% | 14.9% | 11.2% | 8.4% | 14.3% | 14.6% |
| ROA | 3.1% | 3.6% | 1.7% | 3.3% | 5.4% | 3.5% | 4.7% | 3.4% | 2.2% | 3.8% | 4.0% |
| Net Profit Margin | 4.7% | 5.4% | 5.4% | 3.3% | 5.3% | 3.1% | 3.7% | 2.6% | 1.4% | 2.2% | 2.2% |
| Debt to Equity | 0.37x | 0.40x | 1.04x | 0.84x | 0.67x | 0.73x | 0.70x | 0.67x | 0.78x | 0.75x | 0.72x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
The Cigna Group dividends
- Dividend yield
- 2.06%
- Forward dividend
- 6.24 USD
- Payout ratio
- 27.0%
- Ex-dividend date
- Dec 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.61B | 6.06 | 27.0% |
| 2024 | USD 1.57B | 5.53 | 45.6% |
| 2023 | USD 1.45B | 4.88 | 28.1% |
| 2022 | USD 1.38B | 4.42 | 20.6% |
| 2021 | USD 1.34B | 3.93 | 25.0% |
| 2020 | USD 15.0M | 0.04 | 0.2% |
| 2019 | USD 15.0M | 0.04 | 0.3% |
| 2018 | USD 24.3B | 99 | 923.1% |
| 2017 | USD 1.66B | 6.81 | 74.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:1 on Jun 5, 2007.
Who owns The Cigna Group
- Insiders 1.45%
- Institutions 92.86%
- Public & others 5.69%
- Shares outstanding 264M
- Free float 262M
Top funds holding CI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 8.39M | 3.18% | -0.23% | Sep 2026 |
| Dodge & Cox Stock I | 8.13M | 3.09% | +1.80% | Sep 2026 |
| Vanguard 500 Index Investor | 6.94M | 2.63% | -1.23% | Sep 2026 |
| MFS Value A | 4.08M | 1.55% | -2.89% | Sep 2026 |
| iShares Core S&P 500 ETF | 3.52M | 1.34% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 3.43M | 1.30% | +0.01% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 3.22M | 1.22% | -0.25% | Oct 2026 |
| Vanguard Windsor II Inv | 3.09M | 1.17% | +12.97% | Sep 2026 |
| Vanguard MStar Value Index Investor | 2.52M | 0.96% | -0.50% | Sep 2026 |
| State Street®HlthCrSelSectSPDR®ETF | 1.93M | 0.73% | +0.88% | Oct 2026 |
| Vanguard Institutional Index I | 1.40M | 0.53% | -1.15% | Sep 2026 |
| VictoryShares Free Cash Flow ETF | 1.14M | 0.43% | +0.34% | Oct 2026 |
| Strategic Advisers Fidelity US TtlStk | 1.08M | 0.41% | -5.64% | Sep 2026 |
| Vanguard High Dividend Yield ETF | 1.06M | 0.40% | +0.29% | Sep 2026 |
| American Funds American Balanced A | 870K | 0.33% | 0.00% | Sep 2026 |
| JPMorgan Equity Income I | 848K | 0.32% | -10.79% | Sep 2026 |
| Vanguard Health Care ETF | 808K | 0.31% | +0.12% | Sep 2026 |
| JHancock Disciplined Value Mid Cap I | 806K | 0.31% | -0.91% | Aug 2026 |
| State Street® SPDR® Port S&P 500® ETF | 735K | 0.28% | +0.05% | Oct 2026 |
| Invesco S&P 500® Equal Weight ETF | 709K | 0.27% | +0.16% | Oct 2026 |
Top institutions holding CI.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 23.4M | 8.89% | +3.72% | Jun 2026 |
| Vanguard Capital Management, LLC | 17.3M | 6.56% | +0.90% | Jun 2026 |
| State Street Corp | 12.7M | 4.81% | +3.25% | Jun 2026 |
| Dodge & Cox | 12.2M | 4.62% | +5.35% | Jun 2026 |
| Massachusetts Financial Services Company | 10.4M | 3.96% | -9.93% | Jun 2026 |
| Sanders Capital, LLC | 10.1M | 3.83% | -0.46% | Sep 2026 |
| FMR Inc | 8.02M | 3.04% | -26.82% | Jun 2026 |
| Geode Capital Management, LLC | 6.27M | 2.38% | +1.10% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 6.23M | 2.36% | +1.06% | Jun 2026 |
| GQG Partners LLC | 5.91M | 2.24% | -1.56% | Jun 2026 |
| JPMorgan Chase & Co | 5.19M | 1.97% | -10.53% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 3.69M | 1.40% | +7.52% | Jun 2026 |
| NORGES BANK | 3.56M | 1.35% | -3.85% | Jun 2026 |
| Bank of America Corp | 3.00M | 1.14% | -5.65% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 2.85M | 1.08% | -0.38% | Jun 2026 |
| Northern Trust Corp | 2.73M | 1.04% | +1.04% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 2.66M | 1.01% | +5.76% | Sep 2026 |
| Ameriprise Financial Inc | 2.61M | 0.99% | -6.28% | Jun 2026 |
| Grantham, Mayo, Van Otterloo & Co., LLC | 2.58M | 0.98% | -0.81% | Jun 2026 |
| Amvescap Plc. | 2.40M | 0.91% | -3.60% | Jun 2026 |
The Cigna Group company profile
- Company name
- The Cigna Group
- Ticker
- CI.US
- Exchange
- USA Stocks
- Listed since
- Mar 31, 1982
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 65,669
- Fiscal year end
- December
- Address
- 900 Cottage Grove Road, Bloomfield, CT, United States, 06002
- Phone
- 860 226 6000
- Website
- thecignagroup.com
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
The Cigna Group management
10- Mr. David Michael CordaniExecutive Chairman of the Board · born 1965
- Mr. Brian Case Evanko C.F.A.President, CEO & Director · born 1977
- Ms. Ann M. DennisonExecutive VP & CFO · born 1971
- Ms. Nicole Susan Jones J.D.Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer · born 1971
- Mr. F. Everett NevilleExecutive VP & Special Advisor to the CEO · born 1965
- Ms. Jamie KatesSenior VP & Tax and Global Chief Accounting Officer · born 1980
- Mr. Durga Prasad KokaExecutive Vice President & Global Chief Information Officer
- Mr. Ralph GiacobbeSenior Vice President of Investor Relations
- Ms. Andrea NelsonEVP, General Counsel & Corporate Secretary
- Ms. Melissa SkottegaardExecutive Vice President, Chief Marketing & Communications Officer